These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4815338)

  • 41. Conjugated 3,4 dihydroxy phenyl acetic acid (DOPAC) in human and monkey cerebrospinal fluid and rat brain and the effects of probenecid treatment.
    Gordon EK; Markey SP; Sherman RL; Kopin IJ
    Life Sci; 1976 Jun; 18(11):1285-92. PubMed ID: 819753
    [No Abstract]   [Full Text] [Related]  

  • 42. [Changes in ventricular dopamine and homovanillic acid concentrations in hydrocephalic patients (author's transl)].
    Kawano T; Tsujimura M; Mori K; Eujita Y
    Neurol Med Chir (Tokyo); 1980 Apr; 20(4):373-8. PubMed ID: 6155625
    [No Abstract]   [Full Text] [Related]  

  • 43. [Determination of homovanillic acid in the cerebrospinal fluid of Parkinson's disease patients and control group].
    Voto Bernales J; Cruz GA; Davila E
    Rev Neuropsiquiatr; 1973 Mar; 36(1):46-52. PubMed ID: 4793023
    [No Abstract]   [Full Text] [Related]  

  • 44. 5-Hydroxyindole acetic acid and homovanillic acid in cerebrospinal fluid after intrathecal and intravenous administration of probenecid to normal and hydrocephalic dogs.
    Andersson H; von Essen C; Roos BE
    Acta Pharmacol Toxicol (Copenh); 1973; 32(1):139-47. PubMed ID: 4741034
    [No Abstract]   [Full Text] [Related]  

  • 45. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders.
    Kasa K; Otsuki S; Yamamoto M; Sato M; Kuroda H; Ogawa N
    Biol Psychiatry; 1982 Aug; 17(8):877-83. PubMed ID: 7115838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs.
    Sedvall G
    Prog Biochem Pharmacol; 1980; 16():133-40. PubMed ID: 6160594
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of ischemia on monoamine metabolism. Brain monoamine metabolites in cerebrospinal fluid of patients with recent cerebral infarction.
    Stelmasiak Z
    Neuropatol Pol; 1982; 20(1-2):97-105. PubMed ID: 6191248
    [No Abstract]   [Full Text] [Related]  

  • 48. The effect of chlorpromazine on homovanillic acid levels in cerebrospinal fluid of schizophrenic patients.
    Fyrö B; Wode-Helgodt B; Borg S; Sedvall G
    Psychopharmacologia; 1974 Mar; 35(4):287-94. PubMed ID: 4831513
    [No Abstract]   [Full Text] [Related]  

  • 49. Cerebrospinal fluid transmitter metabolites and atmospheric pressure.
    Nordin C; Eklundh T
    Biol Psychiatry; 1996 Oct; 40(7):682-4. PubMed ID: 8886306
    [No Abstract]   [Full Text] [Related]  

  • 50. Pathophysiological studies on schizophrenia with special reference to homovanillic acid concentration in cerebrospin fluid.
    Shimizu T
    Bull Osaka Med Sch; 1979 Jul; 25(1):51-68. PubMed ID: 540184
    [No Abstract]   [Full Text] [Related]  

  • 51. Amphetamine psychosis: behavioral and biochemical aspects.
    Angrist B; Sathananthan G; Wilk S; Gershon S
    J Psychiatr Res; 1974; 11():13-23. PubMed ID: 4461784
    [No Abstract]   [Full Text] [Related]  

  • 52. Rapid elevation of biogenic amine metabolites in human CSF following probenecid.
    Tamarkin NR; Goodwin FK; Axelrod J
    Life Sci I; 1970 Dec; 9(24):1397-408. PubMed ID: 5493322
    [No Abstract]   [Full Text] [Related]  

  • 53. Further observations showing the impact of the probenecid test in movement disorders.
    Vanderheyden JE; Dumont JP; Dekoninck WJ; Mendlewicz J
    Acta Neurol Belg; 1985; 85(3):171-81. PubMed ID: 4013657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The influence of the lying and sitting positions on the gradients of 5-HIAA and HVA in lumbar cerebrospinal fluid.
    Gateless D; Stanley M; Träskman-Bendz L; Gilroy J
    Biol Psychiatry; 1984 Nov; 19(11):1585-9. PubMed ID: 6083808
    [No Abstract]   [Full Text] [Related]  

  • 55. Acid monoamine metabolites in cerebrospinal fluid during methadone maintenance.
    Bowers MB; Kleber HD; Davis L
    Nature; 1971 Aug; 232(5312):581-2. PubMed ID: 4937511
    [No Abstract]   [Full Text] [Related]  

  • 56. Highly sensitive method for the quantitation of homovanillic acid in cerebrospinal fluid.
    Vogt W; Jacob K; Ohnesorge AB; Schwertfeger G
    J Chromatogr; 1980 Oct; 199():191-7. PubMed ID: 7451601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of varient dosages of amphetamine upon endurance.
    Williams MH; Thompson J
    Res Q; 1973 Dec; 44(4):417-22. PubMed ID: 4532274
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of probenecid on 5-hydroxyindoles in cerebrospinal fluid in Down's syndrome.
    Airaksinen EM; Kauko K
    Ann Clin Res; 1973 Dec; 5(6):392-4. PubMed ID: 4275983
    [No Abstract]   [Full Text] [Related]  

  • 59. Mass fragmentographic analysis of homovanillic acid and its homoiso analogue in cerebrospinal fluid using the alpha-dideutero acid as internal standard.
    Fri CG; Wiesel FA; Sedvall G
    Psychopharmacologia; 1974 Mar; 35(4):295-304. PubMed ID: 4831514
    [No Abstract]   [Full Text] [Related]  

  • 60. Neurotransmitter metabolites in the cerebrospinal fluid of man following physostigmine.
    Davis KL; Hollister LE; Goodwin FK; Gordon EK
    Life Sci; 1977 Oct; 21(7):933-6. PubMed ID: 22010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.